Avalo Therapeutics AVTX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 12.71 | 62.71 | -2.29 | -19,199 | -31 | |
| 2025Q2 | 4.99 | 93.09 | 0.74 | -1.93 | -19,315 | -21 |
| 2025Q1 | 8.01 | 111.63 | 1.17 | -1.25 | -14,669 | -13 |
| 2024Q4 | 7.43 | 34.54 | 1.72 | -13,311 | -35 | |
| 2024Q3 | 9.50 | -58.30 | 8.00 | -12,860 | 23 | |
| 2024Q2 | 12.47 | -9.84 | 110.51 | -9,574 | 98 | |
| 2024Q1 | 21.75 | 27.02 | -141.14 | -32,767 | -121 | |
| 2023Q4 | 9.10 | 92.73 | 117.47 | -7,658 | -8 | |
| 2023Q3 | 28.97 | 102.26 | 107.80 | -3,750 | -5 | |
| 2023Q2 | 85.25 | 114.58 | -134.85 | -7,151 | -8 | |
| 2023Q1 | 420.00 | 97.71 | -204.00 | -8,792 | -10 | |
| 2022Q4 | 1209.62 | -250.05 | -8,855 | -10 | ||
| 2022Q3 | 796.80 | 81.53 | 4,095 | 3 | ||
| 2022Q2 | 1440.00 | -330.94 | -11,827 | -13 | ||
| 2022Q1 | 2087.14 | 99.90 | -563.55 | -20,853 | -22 | |
| 2021Q4 | 4896.00 | 20693.97 | -17,963 | -19 | ||
| 2021Q3 | 6278.40 | 99.91 | -21648.41 | -16,463 | -17 | |
| 2021Q2 | 99.97 | -510.75 | -17,128 | -17 | ||
| 2021Q1 | 100.06 | -920.90 | -30,580 | -31 | ||
| 2020Q4 | 100.07 | -518.01 | -16,339 | -16 |